Novo Nordisk posts strong LPG-1 sales amid supply recovery, but warns of future “periodic caps”
With Novo Nordisk’s obesity treatment, Wegovy, fully available again in December, sales are starting to soar, the Danish drugmaker reported during its annual earnings call on Wednesday. Wegovy’s total glucagon-like …
Novo Nordisk posts strong LPG-1 sales amid supply recovery, but warns of future “periodic caps” Read More